The United States continues to play a leading role in advancing neurological care through strong pharmaceutical innovation, extensive clinical research, and a well-established healthcare infrastructure. The growing prevalence of neurological conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, multiple sclerosis, and migraine has increased the demand for advanced therapeutic...